Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rVIII-SingleChain Extension Study in Severe Hemophilia A
NCT02172950Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Oct 2014
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 25
01
Overview
A Phase 3 trial of lonoctocog alfa in hemophilia A, sponsored by CSL Limited. Started Oct 2014; status: completed.
02
Drugs
lonoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02172950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172950.